Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome

David A. Flockhart, Milou Daniel Drici, Thomas Kerbusch, Nadia Soukhova, Emily Richard, Philip L. Pearle, Subena K. Mahal, Victoria J. Babb

Research output: Contribution to journalArticle

66 Scopus citations


The authors report in detail the case of a 27-year-old man who experienced sudden cardiac death 2 days after coprescription of the neuroleptic pimozide and the macrolide antibiotic clarithromycin after the documentation of a prolonged QT interval. To determine the prevalence of this interaction, the authors referred to the Spontaneous Reporting System of the Food and Drug Administration and identified one similar case in which clarithromycin was coprescribed with pimozide and sudden cardiac death occurred shortly thereafter. In addition, the search identified 39 cases of cardiac arrhythmia associated with pimozide, 11 with pimozide alone, and 6 with clarithromycin alone, 1 of which had a positive rechallenge. The mechanism of the interaction between clarithromycin and pimozide seems to involve the inhibition of the hepatic metabolism of pimozide by the macrolide. The authors demonstrated that clarithromycin is able to inhibit the metabolism of pimozide in human liver microsomal preparations (K(i) = 7.65 ± 1.18 μM) and that pimozide, but not clarithromycin or its primary metabolite, is able to prolong the electrocardiac QT interval in a dose- dependent manner in the isolated perfused rabbit heart. The increase was 9.6 ± 1.1% in male hearts (N = 5) and 13.4 ± 1.2% in female hearts (N = 4) (p < 0.05).

Original languageEnglish (US)
Pages (from-to)317-324
Number of pages8
JournalJournal of Clinical Psychopharmacology
Issue number3
StatePublished - Jun 1 2000


ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Flockhart, D. A., Drici, M. D., Kerbusch, T., Soukhova, N., Richard, E., Pearle, P. L., Mahal, S. K., & Babb, V. J. (2000). Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome. Journal of Clinical Psychopharmacology, 20(3), 317-324.